Riyadh Biotechnology Summit Yields Over 5B Riyals
The Riyadh Global Biotechnology Medical Summit 2026 concluded its activities by signing over 40 agreements and investment initiatives valued at more than 5 billion riyals, aimed at promoting the localization of advanced pharmaceutical industries and supporting innovation in the field of biotechnology. The summit, which took place from September 14 to 16, saw widespread international participation from more than 57 countries, with over 200 speakers and more than 80 sessions focused on AI research, genomics, vaccine manufacturing, and other topics. The accompanying exhibition attracted more than 120 exhibitors and investors, with major investment funds preparing to inject over $120 million to support startups in the sector, reflecting the Kingdom's efforts to bolster and localize the biotechnology sector within the framework of the national strategy.
Notice: This Is an AI-Generated Summary
Comments (0)